
浏览全部资源
扫码关注微信
1. 池州市人民医院肾内科
2. 池州市人民医院中医科
纸质出版日期:2020,
扫 描 看 全 文
[1]徐黄根,桂牧微,吴岳春,丁红莲.固元祛浊汤改善维持性血液透析患者高磷血症的效果及机制探讨[J].中国医院用药评价与分析,2020,20(02):224-227+231.
XU Huanggen, GUI Muwei, WU Yuechun, et al. Effect and Mechanism of Guyuan Quzhuo Decoction in Improving Hyperphosphatemia in Patients Undergoing Maintenance Hemodialysis[J]. 2020,20(2):224-227.
[1]徐黄根,桂牧微,吴岳春,丁红莲.固元祛浊汤改善维持性血液透析患者高磷血症的效果及机制探讨[J].中国医院用药评价与分析,2020,20(02):224-227+231. DOI: 10.14009/j.issn.1672-2124.2020.02.026.
XU Huanggen, GUI Muwei, WU Yuechun, et al. Effect and Mechanism of Guyuan Quzhuo Decoction in Improving Hyperphosphatemia in Patients Undergoing Maintenance Hemodialysis[J]. 2020,20(2):224-227. DOI: 10.14009/j.issn.1672-2124.2020.02.026.
目的:探讨固元祛浊汤改善维持性血液透析(maintenance hemodialysis
MHD)患者高磷血症的效果
并探究其机制。方法:纳入2018年池州市人民医院收治的MHD患者80例
按照信封法分为观察组和对照组
每组40例。对照组患者给予常规治疗
观察组患者在对照组基础上加用固元祛浊汤治疗。观察两组患者治疗前后的血钙、血磷、钙磷乘积、甲状旁腺激素(PTH)、血尿素氮(BUN)及血肌酐(Scr)水平
记录治疗前后中医证候积分
评价治疗效果及安全性。结果:观察组患者的总有效率为87. 50%(35/40)
明显高于对照组的65. 00%(26/40)
差异有统计学意义(P<0. 05)。治疗后
两组患者各中医证候积分、总积分均明显低于治疗前
且观察组患者腰膝酸软、倦怠乏力、口干舌燥、肢体肿胀、口中胺味及骨痛等证候积分和总积分均明显低于对照组
差异均有统计学意义(P<0. 05);观察组患者的血磷、钙磷乘积、PTH及Scr等指标水平明显低于本组治疗前和对照组治疗后
差异均有统计学意义(P<0. 05)。治疗过程中
两组患者均未见明显不良反应。结论:固元祛浊汤用于MHD高磷血症患者的治疗
可改善机体钙磷水平
疗效确切
其机制可能与降低PTH分泌及改善肾功能相关。
OBJECTIVE: To investigate the effects of Guyuan Quzhuo decoction in improving hyperphosphatemia in patients undergoing maintenance hemodialysis( MHD)
and to explore its mechanism. METHODS: Totally 80 patients with MHD admitted into Chizhou People’s Hospital in 2018 were extracted to be divided into the observation group and the control group via the envelope method
with 40 cases in each group. The control group was given conventional treatment
while the observation group was treated with Guyuan Quzhuo decoction on the basis of the control group. Blood calcium
blood phosphorus
calcium-phosphorus product
parathyroid hormone( PTH)
blood urea nitrogen( BUN)
and serum creatinine( Scr) levels of two groups were observed before and after treatment
traditional Chinese medicine( TCM) symptom scores were recorded before and after treatment. The treatment efficacy and safety were evaluated. RESULTS: The total effective rate of the observation group was 87. 50%( 35/40)
significantly higher than 65. 00%( 26/40) of the control group
and the difference was statistically significant( P <0. 05). After treatment
the TCM symptom scores and total scores of two groups were significantly lower than those before treatment; in the observation group
the symptom scores and total scores of waist and knee weakness
fatigue
dry mouth
swelling of the limbs
amine taste in the mouth and bone pain were significantly lower than those in the control group
and the differences were statistically significant( P <0. 05). The levels of blood phosphorus
calciumphosphate product
PTH and Scr in the observation group were significantly lower than those before treatment and the control group after treatment
and the differences were statistically significant( P < 0. 05). During the treatment
no significant adverse drug reactions were observed in both groups. CONCLUSIONS: Guyuan Quzhuo decoction can be used in the treatment of hyperphosphatemia in patients undergoing MHD
which can improve the body’s calcium and phosphorus levels. The effect is definite
and the mechanism may be related to the reduction of PTH secretion and the improvement of renal function.
固元祛浊汤维持性血液透析高磷血症终末期肾脏病
Guyuan Quzhuo decoctionMaintenance hemodialysisHyperphosphatemiaEnd-stage renal disease
0
浏览量
39
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621